As you prepare to launch ambitious new projects in 2017, I’d like to personally encourage you to explore the wide array of services and expertise Lovelace Biomedical provides in toxicology, pharmacology, formulation and more. While Lovelace is the same not-for-profit CRO you’ve always known—with a deep history of excellence in respiratory research—today, we offer much more.
Last year, Lovelace Biomedical emerged from the Lovelace Family of Companies as a standalone business unit with a clear mission: to help pharmaceutical and biotechnology companies advance new compounds, medical technologies across a wide range of disease areas. To be clear, this is the work we’ve been doing for decades. However, we had been doing it rather quietly. So last year, rather than continuing as the biomedical industry’s best-kept secret, we decided to sing a little louder.
We have made significant new investments in staff, project management, and animal housing infrastructure, which means we’re prepared now more than ever to help you achieve your nonclinical research goals — including GLP IND/NDA-enabling studies across an array of therapeutic areas such as gene therapy, infectious diseases, dermatitis and CNS disorders.
Operating within 300,000 square feet of laboratory space, Lovelace Biomedical takes pride its ability to excel with nearly any therapeutic program, no matter how complex. Our team includes expert toxicologists, chemists, veterinarians, pathologists, pharmacologists, project managers and more.
In addition, Lovelace maintains high standards for humane and ethical treatment of animals involved in research. Lovelace has been accredited with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) since 1970, demonstrating our commitment to responsible animal care and use; and is registered and certified with the United States Department of Agriculture (USDA) as a Class R Research Facility, upholding compliance to the Animal Welfare Act.
Please browse our website at contact us to learn more about how we can help advance your programs. On behalf of the entire team at Lovelace Biomedical, we look forward to working with you.
Jake McDonald, Ph.D. is Lovelace Biomedical’s chief scientific officer.